InvestorsHub Logo

kabunushi

05/18/24 11:47 PM

#692536 RE: sentiment_stocks #692506

I'm pretty sure OP was just trolling. IMO, nobody who does any actual DD could be as ignorant as they make themself out to be.

exwannabe

05/19/24 9:21 AM

#692557 RE: sentiment_stocks #692506

The German treatment is NOT the same as DCVax-L as the German version is missing the patient’s tumor lysate… which is kinda key.


Not true. ATL-DC is available in German clinics.

See this clinic for example.


Two components are required for manufacturing an individual cancer vaccine:

. Patient's immune cells.
. Components of the patient's tumor.

The first one is obtained during the leukapheresis procedure, when about 200 ml of blood is collected from the patient's vein. German specialists immediately separate the blood into components and return plasma, erythrocytes, platelets, and unnecessary leukocyte fractions to the patient. To manufacture a vaccine, only one type of immune cell is used, i.e. monocytes. Leukapheresis takes a little time and has no side effects.

The harvested monocytes are cultivated in a GMP-certified laboratory, where healthcare professionals stimulate their transformation into dendritic cells. Young dendritic cells actively multiply on a nutrient medium. After receiving the required amount of cellular material, they are "acquainted" with the components of glioblastoma. This can be a tumor lysate (if a biopsy or surgery was performed) or synthetic glioblastoma peptides (if there were no interventions). As a result, dendritic cells are trained to resist the tumor masking and stimulate the destruction of its cells.



Also is available in India as we know.

Now, being an ATL-DC does not make it DCVax-L in my book, but most all longs think it does.

iclight

05/19/24 1:05 PM

#692607 RE: sentiment_stocks #692506

It’s equally ineffective though.